FindTrial
Sign In

Efficacy of oral MIFEPRISTONE for pre induction cervical ripening in term pregnancy

Efficacy of Oral Mifepristone for Pre-Induction Cervical Ripening in term Pregnancy : A Prospective Randomized Single Blind Controlled Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/09/057908
Enrollment
82
Registered
2023-09-21
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Tablet MIFEPRISTONE 200mg given orally for pre induction cervical ripening : Group A: after assessment of bishop score term pregnant women with score less than 6 are induced with Mifepr

Sponsors

Shri Dharmastala Manjunatheshwara College of Medical Sciences and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Primigravida, Cephalic presentation, between 37-42 weeks of gestation, unripe cervix ( bishop score 18 years, at admission NST reactive, intact membranes.

Exclusion criteria

Exclusion criteria: Multigravida, contra indications for induction of labour, estimated fetal weight > 4.5 kg or <2.5 kg, antepartum haemorrhage, chorioamniotis.

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of Mifepristone for pre induction cervical ripeningTimepoint: measured at baseline (after 24hours)—

Secondary

MeasureTime frame
To evaluate outcome of labour to study fetal & maternal complicationsTimepoint: after each delivery outcome measured at baseline—

Countries

India

Contacts

Public ContactDr Voorkara Udayashree

Shri Dharmastala Manjunatheshwara College of Medical Sciences and Hospital

drudayashree@yahoo.com984560821

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026